J. P. Wereley

发表

mutation Iron transport in a lymphoid cell line with the hemochromatosis C282Y

C. Chitambar, J. P. Wereley, 2013 .

Iron transport in a lymphoid cell line with the hemochromatosis C282Y mutation.

C. Chitambar, J. P. Wereley, 2001, Blood.

Transferrin receptor-dependent and -independent iron transport in gallium-resistant human lymphoid leukemic cells.

C. Chitambar, J. P. Wereley, 1998, Blood.

Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells.

R. Haq, C. Chitambar, J. P. Wereley, 1995, Experimental hematology.

Expression of the hemochromatosis gene modulates the cytotoxicity of doxorubicin in breast cancer cells

S. Kotamraju, C. Chitambar, J. P. Wereley, 2006, International journal of cancer.

Expression of the hemochromatosis (HFE) gene modulates the cellular uptake of 67Ga.

C. Chitambar, J. P. Wereley, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase

K. Schmainda, J. Kuo, P. Clark, 2018, Molecular Cancer Therapeutics.

Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition

S. Matsuyama, C. Chitambar, J. P. Wereley, 2006, Molecular Cancer Therapeutics.

Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.

C. Chitambar, J. P. Wereley, 1995, Cancer research.

Resistance to the Antitumor Agent Gallium Nitrate in Human Leukemic Cells Is Associated with Decreased Gallium/Iron Uptake, Increased Activity of Iron Regulatory Protein-1, and Decreased Ferritin Production*

C. Chitambar, J. P. Wereley, 1997, The Journal of Biological Chemistry.

Development of Gallium Compounds for Treatment of Lymphoma: Gallium Maltolate, a Novel Hydroxypyrone Gallium Compound, Induces Apoptosis and Circumvents Lymphoma Cell Resistance to Gallium Nitrate

Meiying Yang, J. Woodliff, C. Chitambar, 2007, Journal of Pharmacology and Experimental Therapeutics.

Cellular adaptation to down-regulated iron transport into lymphoid leukaemic cells: effects on the expression of the gene for ribonucleotide reductase.

W. O'brien, W. Antholine, C. Chitambar, 2000, Biochemical Journal.

Increased sensitivity of hydroxyurea-resistant leukemic cells to gemcitabine.

C. Chitambar, S. Wong, J. P. Wereley, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.

P. Boon, C. Chitambar, J. P. Wereley, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase

K. Schmainda, J. Kuo, P. Clark, 2018, Molecular Cancer Therapeutics.